In a recent article, BioInformant compared the top three largest cord blood banks within the United States. The purpose of the analysis was to consider comparative metrics between the largest market leaders in the cord blood industry within the United States, the most mature cord blood market worldwide. [Read more…]
Cord Blood
Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.
Top Innovators in MSC Research Products: Who’s Leading in 2026?
The field of mesenchymal stem cell (MSC) research continues to gain momentum as scientists and innovators push the boundaries of regenerative medicine, tissue engineering, and biotechnology. From developing engineered tissues to advancing cell-based therapies, MSCs are at the heart of these groundbreaking efforts. As a result, the demand for high-quality MSC research products has grown rapidly. Whether you’re involved with research, clinical applications, or biomanufacturing, knowing where to find reliable MSC tools is essential for success. [Read more…]
SB431542 Unlocking the Potential of Mouse Embryonic Stem Cells
Mouse embryonic stem cells (mESCs) have long stood as a cornerstone of regenerative medicine and developmental biology research. Derived from the inner cell mass of blastocyst-stage mouse embryos, these cells possess two defining characteristics: pluripotency, the ability to differentiate into any cell type in the adult body, and self-renewal, the capacity to divide indefinitely while maintaining that pluripotent state. Harnessing these properties, however, requires precise control over the cellular signaling pathways that govern mESC fate. This is where SB431542, a small molecule inhibitor, emerges as a powerful tool—one that has revolutionized how researchers manipulate mESCs in the lab. [Read more…]
Cord Blood Industry Trends – Clinical Trials, Publications, Patents, Grants, & More
With the global cord blood banking industry maturing and consolidating over the past five years, it is more important than ever to be well-educated about cord blood industry trends. There are now fewer market players, because numerous small cord blood banks have either been acquired or gone out of business.
However, this era of maturation and consolidation has had as many benefits to surviving cord blood banks as drawbacks. On average, the remaining market participants are now larger, stronger, better capitalized, and storing larger quantities of cord blood and tissue units than when the market was more fragmented.
Therapeutic Applications of Umbilical Cord Blood & Tissue Proliferate in 2026
Cancer treatment using very high-dose chemotherapy or radiation therapy often results in severe injury to a patient’s blood-forming cells, called their hematopoietic (“blood formation”) system. Therefore, radiation therapy is soon followed by hematopoietic stem cell transplantation (HSCT), which is a method of reconstructing a patient’s blood system that has been destroyed by cancer treatment. Cord blood can also be used as a source of stem cells for hematopoietic stem cell transplantation (HSCT), providing an important alternative to the traditional options of peripheral blood and bone marrow transplant. Importantly, bone marrow and peripheral blood require full tissue matching for use in HSCT, while umbilical cord blood only requires partial matching. [Read more…]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 62
- Next Page »